Health · 1 views
Predicting response to biologics for severe asthma through breath analysis
Severe eosinophilic asthma can now be treated with biologic therapies that reduce attacks and, in some cases, allow corticosteroid dose reductions.
Health 
Story intelligence
Coverage Single outlet Single-outlet story
Views 1 Community interest
Brief read Under 1 min brief 33 words
AI Summary
Severe eosinophilic asthma can be treated with biologic therapies that reduce attacks and sometimes allow corticosteroid dose reductions. However, not all patients respond to these treatments, and predicting who will benefit remains difficult.
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedMore from Health
Continue reading recent Health coverage
- Observational study links prenatal paracetamol exposure to altered reproductive development in daughtersContinue reading
- NYC officials release unseen post-9/11 air quality documentsContinue reading
- Sugar substitutes fail to fuel sweet cravings or weight gain across yearlong trialsContinue reading
- Incidence of acute kidney injury is higher in summer, especially among young people in JapanContinue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow